Chapter 1 Molecular aspects of prolactin and growth hormone receptors

Advances in Molecular and Cellular Endocrinology

Volumn 2, Issue C, 1998, Pages 1-33

  Goffin, Vincent ^a   Ferrag, Fatima ^a   Kelly, Paul A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957064949     PISSN: 15692566     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2566(98)80009-4     Document Type: Article

References (139)

1. Abdel-Meguid S.S., Shieh H.S., Smith W.W., Dayringer H.E., Violand B.N., and Bentle L.A. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl. Acad. Sci. USA 84 (1987) 6434-6437
2. Adachi M., Fisher E.H., Ihle J., Imai K., Jirik F., Neel B., Pawson T., Shen S.H., Thomas M., Ullrich A., and Zhao Z. Mammalian SH2-containing protein tyrosine phosphatases. Cell 85 (1996) 15
3. Ali S., Pellegrini I., Edery M., Lesueur L., Paly J., Djiane J., and Kelly P.A. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J. Biol. Chem. 266 (1991) 20110-20117
4. Ali S., Chen Z., Lebrun J.J., Vogel W., Kharitonenkov A., Kelly P.A., and Ullrich A. PTP1D is a positive regulator of the prolactin signal leading to β-casein promoter activation. EMBO J. 15 (1996) 135-142
5. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., and Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 (1993) 237-244
6. Argetsinger L.S., Ilsu G.W., Myers M.G., Billestrup N., White M., and Carter-Su C. Growth hormone, interferon-g, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270 (1995) 14685-14692
7. Avruch J., Zhang X.-f., and Kyriakis J.M. Raf meets Ras: completing the framework of a signal transduction pathway. TIBS 19 (1994) 279-283
8. Bass S.H., Mulkerrin M.G., and Wells J.A. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad. Sci. USA 88 (1991) 4498-4502
9. Baumann G. Growth hormone-binding protein: errant receptor or active player. Endocrinology 136 (1995) 377-378
10. Baumbach W.R., Horner D.L., and Logan J.S. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev. 3 (1989) 1199-1205
11. Baumgartner J.W., Wells C.A., Chen C.M., and Waters M.J. The role of the WSxWS motif in growth hormone receptor function. J. Biol. Chem. 269 (1994) 29094-29101
12. Bazan F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and p75-IL-2 receptor β-chain. Biochem. Biophys. Res. Commun. 164 (1989) 788-795
13. Bazan J.F. Structural design of molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87 (1990) 6934-6938
14. Beadling C., Ng J., Baddage J.W., and Cantrell D.A. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15 (1996) 1902-1913
15. Berlanga J.J., Fresno Vara J.A., Martin-Perez J., and Garcia-Ruiz J.P. Prolactin receptor is associated with c-src kinase in rat liver. Mol. Endocrinol. 9 (1995) 1461-1467
16. 2+ oscillations and gene transcription. Proc. Natl. Acad. Sci. USA 92 (1995) 2725-2729
17. Boutin J.M., Jolicoeur C., Okamura H., Gagnon J., Edery M., Shirota M., Banville D., Dusanter-Fourt I., Djiane J., and Kelly P.A. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53 (1988) 69-77
18. Buckley A.R., Crowe P.D., and Russel H. Rapid activation of a proteine kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc. Natl. Acad. Sci. USA 85 (1988) 8649-8653
19. Buckley A.R., Rao Y.-P., Buckley D.J., and Gout P.W. Prolactin-induced phosphorylation and nuclear translocation of MAP Kinase in Nb2 lymphoma cells. Biochem. Biophys. Res. Commun. 204 (1994) 1158-1164
20. Campbell G.S., Pang L., Miyasaka T., Saltiel A.R., and Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F422A fibroblasts. J. Biol. Chem. 267 (1992) 6074-6080
21. Campbell G.S., Argetsinger L.S., Ihle J.N., Kelly P.A., Rillema J.A., and Carter-Su C. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. USA 91 (1994) 5232-5236
22. Campbell G.S., Meyer D.J., Raz R., Levy D.E., Schwartzt J., and Carter-Su C. Activation of acute phase response factor (APRF)/stat3 transcription factor by growth hormone. J. Biol. Chem. 270 (1995) 3974-3979
23. Caravella J.A., Lyne P.D., and Richards W.C. A partial model of the erythropoietin receptor complex. Proteins 24 (1996) 394-401
24. Carter-Su C., Stubbart J.R., Wang X., Stred S.E., Argetsinger L.S., and Shafer J.A. Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. J. Biol. Chem. 264 (1989) 18654-18661
25. Clarckson T., and Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267 (1995) 383-386
26. Clevenger C.V., and Medaglia M.V. The protein tyrosine kinase p59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8 (1994) 674-681
27. Clevenger C.V., Torigoe T., and Reed J.C. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J. Biol. Chem. 269 (1994) 5559-5565
28. Clevenger C.V., Chang W.P., Ngo W., Pasha T.L.M., Montone K.T., and Tomaszewski J.E. Expression of prolactin and prolactin receptor in human breast carcinoma. Am. J. Pathol. 146 (1995) 695-705
29. Colosi P., Wong K., Leong S.R., and Wood W.I. Mutational analysis of the intracellular domain of the human growth hormone receptor. J. Biol. Chem. 268 (1993) 12617-12623
30. Cunningham B.C., and Wells J.A. High-resolution epitope mapping in hGH-receptor interactions by alanine-scanning mutagenesis. Science 244 (1989) 1081-1084
31. Cunningham B.C., Ultsch M., De Vos A.M., Mulkerrin M.G., Clauser K.R., and Wells J.A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254 (1991) 821-825
32. Cunningham B.C., and Wells J.A. Rational design of receptor-specific variants of human growth hormone. Proc. Natl. Acad. Sci. USA 88 (1991) 3407-3411
33. Daniel N., Waters M.J., Bignon C., and Djiane J. Involvement of a subset of tyrosine kinases and phosphatases in regulation of the β-lactoglobulin gene promoter by prolactin. Mol. Cell. Endocrinol. 118 (1996) 25-35
34. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
35. Das R., and Vonderhaar B.K. Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol. Endocrinol. 9 (1995) 1750-1759
36. DaSilva L., Howard O.M.Z., Rui H., Kirken R.A., and Farrar W.L. Growth signaling and Jak2 association mediated by membrane-proximal regions of prolactin receptors. J. Biol. Chem. 269 (1994) 18267-18270
37. DaSilva L., Rui H., Erwin R.A., Zack Howard O.M., Kirken R.A., Malabarba M.G., Hackett R.H., Larner A.C., and Farrar W.L. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR476, TYR515 and TYR580. Mol. Cell. Endocrinol. 117 (1996) 131-140
38. David M., Petricoin III E.F., Igarashi K.-I., Feldman G.M., Finbloom D.S., and Larner A.C. Prolactin activates the interferon-regulated p91transcription factor and the Jak2 kinase by tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 91 (1994) 7174-7178
39. De Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
40. Dinerstein H., Lago F., Goujon L., Ferrag F., Esposito N., Finidori J., Kelly P.A., and Postel-Vinay M.C. The proline-rich region of the growth hormone receptor is essential for Jak2 phosphorylation, activation of cell proliferation and gene transcription. Mol. Endocrinol. 9 (1995) 1701-1707
41. Doglio A., Dani C., Grimaldi P., and Ailhaud G. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc. Natl. Acad. Sci. USA 86 (1989) 1148-1152
42. Duan W.R., Linzer D.I.H., and Gibori G. Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J. Biol. Chem. 271 (1996) 15602-15607
43. Duquesnoy P., Sobrier M.L., Duriez B., Dastot F., Buchanan C.R., Savage M.O., Preece M.A., Craescu C.T., Blouquit Y., Goossens M., and Amselem S. A single amino acid substitution in the exoplasmic domain of human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13 (1994) 1386-1395
44. Duriez B., Sobrier M.L., Duquesnoy P., Tixier-Boichard M., Decuypere E., Coquerelle G., Zeman M., Goossens M., and Amselem S. A naturally occuring growth hormone receptor mutation: in vivo and in vitro evidence for the functional importance of the WS motif common to all members of the cytokine receptor superfamily. Mol. Endocrinol. 7 (1993) 806-814
45. Dusanter-Fourt I., Muller O., Ziemiecki A., Mayeux P., Drucker B., Djiane J., Wilks A., Harper A.G., Fischer S., and Gisselbrecht S. Identification of Jak protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO J. 13 (1994) 2583-2591
46. Erpel T., and Courtneidge S.A. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell. Biol. 7 (1995) 176-182
47. Erwin R.A., Kirken R.A., Malabarba M.G., Farrar W.L., and Rui H. Prolactin activates ras via signaling proteins Shc, growth factor receptor bound 2, and Son of Sevenless. Endocrinology 136 (1996) 3512-3518
48. Ferrag F., Chiarenza A., Goffin V., and Kelly P.A. Convergence of signaling transduced by PRL/cytokine chimeric receptors on PRL-responsive gene transcription. Mol. Endocrinol. 10 (1996) 451-460
49. Finidori J., and Kelly P.A. Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal trnasducers and activators of transcription. J. Endocrinol. 147 (1995) 11-23
50. Frank S.J., Yi W., Zhao Y., Goldsmith J.F., Gilliland G., Jiang J., Sakai I., and Kraft A.S. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270 (1995) 14776-14785
51. Fuh G., Cunningham B.C., Fukunaga R., Nagata S., Goeddel D.V., and Wells J.A. Rational design of potent antagonists to the human grwoth hormone receptor. Science 256 (1992) 1677-1679
52. Fuh G., Colosi P., Wood W.I., and Wells J.A. Mechanism-based design of prolactin receptor antagonists. J. Biol. Chem. 268 (1993) 5376-5381
53. Fuh G., and Wells J.A. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270 (1995) 13133-13137
54. Fujii H., Nakagawa Y., Schindler U., Kawahara A., Mori H., Gouilleux F., Groner B., Ihle J.N., Minami Y., Miyazaki T., and Taniguschi T. Activation of STAT5 by interleukin 2 requires a carboxy-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92 (1995) 5482-5486
55. Galsgaard E.D., Gouilleux F., Groner B., Serup P., Nielsen J.H., and Billestrup N. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol. Endocrinol. 10 (1996) 652-660
56. Gerhartz C., Heesel B., Sasse J., Hemman U., Landgraf C., Schneider-Mergener J., Horn F., Heinrich P.C., and Graeve L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal trnasducer gp130. I. Definition of a novel phosphotyrosine motif mediating Stat1 activation. J. Biol. Chem. 271 (1996) 12991-12998
57. Ginsburg E., and Vonderhaar B.K. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55 (1995) 2591-2595
58. Goffin V., Norman M., and Martial J.A. Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Mol. Endocrinol. 6 (1992) 1381-1392
59. Goffin V., Struman I., Mainfroid V., Kinet S., and Martial J.A. Evidence for a second receptor binding site on human prolactin. J. Biol. Chem. 269 (1994) 32598-32606
60. Goffin V., Martial J.A., and Summers N.L. Use of a model to understand prolactin and growth hormone specificities. Prot. Eng. 8 (1995) 1215-1231
61. Goffin V., Kinet S., Ferrag F., Binart N., Martial J.A., and Kelly P.A. Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. J. Biol. Chem. 271 (1996) 16573-16579
62. Goffin V., Shiverick K.T., Kelly P.A., and Martial J.A. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocr. Rev. 17 (1996) 385-410
63. Gouilleux F., Wakao H., Mundt M., and Groner B. Prolactin induces phosphorylation of Tyr694 of STAT5(MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13 (1994) 4361-4369
64. Gouilleux F., Pallard C., Dusanter-Fourt I., Wakao H., Haldosen L.-A., Norstedt G., Levy D., and Groner B. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-STAT5 DNA binding activity. EMBO J. 14 (1995) 2005-2013
65. Goujon L., Allevato G., Simonin G., Paquereau L., Le Cam A., Clark J., Nielsen J.H., Djiane J., Postel-Vinay M.C., Edery M., and Kelly P.A. Cytoplasmic domains of the growth hormone receptor necessary for signal transduction. Proc. Natl. Acad. Sci. USA 91 (1994) 957-961
66. Gourdou I., Gabou L., Paly J., Kermabon A.Y., Belair L., and Djiane J. Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. Mol. Endocrinol. 10 (1996) 45-56
67. Gronowski A.M., and Rotwein P. Rapid changes in nuclear protein tyrosine phosphorylation after Growth Hormone treatment in vivo. J. Biol. Chem. 269 (1994) 7874-7878
68. Gupta S., Yan H., Wong L.H., Ralph S., Krolewski J., and Schindler C. The SH2 domains of STAT1 and STAT2 mediate multiple interactions in the transduction of INF-α signals. EMBO J. 15 (1996) 1075-1084
69. Hackett R.H., Wang Y.D., and Larner A.C. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of JAK2 and STAT proteins. J. Biol. Chem. 270 (1995) 21326-21330
70. Hemman U., Gerhartz C., Heesel B., Sasse J., Kurapkat G., Grötzinger J., Wollmer A., Zhong Z., Darnell Jr. J.E., Graeve L., Heinrich P.C., and Horn F. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define specificity of stat factor activation. J. Biol. Chem. 271 (1996) 12999-13007
71. Hilton D.J., Watowich S.S., Katz L., and Lodish H.F. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 271 (1996) 4699-4708
72. Hooper K.P., Padmanabhan R., and Ebner K.E. Expression of the extracellular domain of the rat liver prolactin receptor and its interaction with ovine prolactin. J. Biol. Chem. 268 (1993) 22347-22352
73. Horseman N.D., and Yu-Lee L.Y. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr. Rev. 15 (1994) 627-649
74. Ihle J.N. Signaling by the cytokine receptor superfamily. Just another kinase story. Trends Endocrinol. Metab. 5 (1994) 137-143
75. Ihle J.N., and Kerr I.M. Jaks and STATs in signaling by the cytokine receptor superfamily. TIG 11 (1995) 69-74
76. Ihle J.N. STATs: signal transducers and activators of transcription. Cell 84 (1996) 331-334
77. Ihle J.N. STATs and MAPKs: obligate or opportunistic partners in signaling. Bioessays 18 2 (1996) 95-98
78. Ilondo M.M., De Meyts P., and Bouchelouche P. Human growth hormone increases cytosolic free calcium in cultured human IM-9 lymphocytes: a novel mechanism of growth hormone transmembrane signalling. Biochem. Biophys. Res. Commun. 202 (1994) 391-397
79. Kazansky A.V., Raught B., Lindsey S.M., Wang Y.F., and Rosen J.M. Regulation of mammary gland factor/STAT5a during mammary gland development. Mol. Endocrinol. 9 (1996) 1598-1609
80. Kelly P.A., Djiane J., Postel-Vinay M.C., and Edery M. The prolactin/growth hormone receptor family. Endocr. Rev. 12 (1991) 235-251
81. Kinet S., Goffin V., Mainfroid V., and Martial J.A. Characterization of lactogen receptor binding site 1 of human prolactin. J. Biol. Chem. 271 (1996) 14353-14360
82. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 253-262
83. Kitamura T., Ogorochi T., and Miyajima A. Multimeric cytokine receptors. Trends Endocrinol. Metab. 5 (1994) 8-14
84. Kossiakoff A.A., Somers W., Ultsch M., Andow K., Muller Y.A., and De Vos A.M. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 3 (1994) 1697-1705
85. Lebrun J.J., Ali S., Sofer L., Ullrich A., and Kelly P.A. Prolactin induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase. J. Biol. Chem. 269 (1994) 14021-14026
86. Lebrun J.J., Ali S., Goffin V., Ullrich A., and Kelly P.A. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA 92 (1995) 4031-4035
87. Lebrun J.J., Ali S., Ullrich A., and Kelly P.A. Proline-rich sequence-mediated JAK2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 270 (1995) 10664-10670
88. Lesueur L., Edery M., Paly J., Kelly P.A., and Djiane J. Roles of the extracellular and cytoplasmic domains of the prolactin receptor in signal transduction to milk protein genes. Mol. Endocrinol. 7 (1993) 1178-1184
89. Leung D.W., Spencer S.A., Chachianes G., Hammonds R.G., Collins C., Henzel W.J., Barnard R., Waters M.J., and Wood W.I. Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature 330 (1987) 537-543
90. Levy D.E., Kessler D.S., Pine R.I., and Darnell J.E. Cytoplasmic activation of ISGF3, the positive regulator of interferon-α stimulated transcription, reconstitued in vitro. Genes Dev. 3 (1989) 1362-1372
91. Liu J. Protein kinase C and its substrates. Mol. Cell. Endocrinol. 116 (1996) 1-29
92. Livnah O., Stura E.A., Johnson D.L., Middleton S.A., Mulcahy L.S., Wrighton N.C., Dower W.J., Jolliffe L.K., and Wilson I.A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273 (1996) 464-471
93. Lobie P.E., Allevato G., Nielsen J.H., Norstedt G., and Billestrup N. Requirement of tyrosine residues 333 and 338 of the growth hormone (GH) receptor for selected GH-stimulated function. J. Biol. Chem. 270 (1995) 21745-21750
94. Lütticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki, Harpur A.G., Wilks A.F., Yasakawa K., Taga T., Kishimoto T., Barbieri G., Pellegrini S., Sendtner M., Heinrich P.C., and Horn F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263 (1994) 89-91
95. Meyer D.J., Campbell G.S., Cochran B.H., Argetsinger L.S., Larner A.C., Finbloom D.S., Carter-Su C., and Schwartz J. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J. Biol. Chem. 269 (1994) 4701-4704
96. Miyazaki T., Maruyama M., Yamada G., Hatakeyama M., and Taniguchi T. The intergity of the conserved WS motif common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J. 10 (1991) 3191-3197
97. Mui A.L.-F., Wakao H., O'Farrell A.-M., Harada N., and Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 14 (1995) 1166-1175
98. Mui A.L., Wakao H., Kinoshita T., Kitamura T., and Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15 (1996) 2425-2433
99. Murakami M., Narazaki M., Hibi M., Yawata H., Yazukawa K., Hamaguchi M., Taga T., and Kishimoto T. Critical cytoplasmic region of the IL-6 signal transducer, gp 130, is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88 (1991) 11349-11353
100. Nagano M., Chastre E., Choquet A., Bara J., Gespach C., and Kelly P.A. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am. J. Physiol. 268 (1995) G431-G442
101. O'Neal K.D., and Yu-Lee L.Y. Differential signal transduction of the short, Nb2 and long prolactin receptors. J. Biol. Chem. 269 (1994) 26076-26082
102. O'Neal K.D., Chari M.V., McDonald C.H., Cook R.G., Yu-Lee L.Y., Morrisett J.D., and Shearer W.T. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD, and NMR. Biochem. J. 315 (1996) 833-844
103. Ormandy C.J., Camus A., Barra J., Damotte D., Lucas B.K., Buteau H., Edery M., Brousse N., Babinet C., Binart N., and Kelly P.A. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11 (1997) 167-178
104. Pallard C., Gouilleux F., Charon M., Groner B., Gisselbrecht S., and Dusanter-Fourt I. Interleukin-3, erythropoietin and prolactin activate a STAT5 like factor in lymphoid cells. J. Biol. Chem. 270 (1995) 15942-15945
105. Piccoletti R., Maroni P., Bendinelli P., and Bernelli-Zazzera A. Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303 (1994) 429-433
106. Postel-Vinay M.C., Belair L., kayser C., Kelly P.A., and Djiane J. Identification of prolactin and growth hormone binding proteins in milk. Proc. Natl. Acad. Sci. USA 88 (1991) 6687-6690
107. Quelle D.E., Quelle F.W., and Wojchowski D.M. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization. Mol. Cell. Biol. 12 (1992) 4553-4561
108. Quelle F.W., Wang D., Nosaka T., Thierfelder W.E., Stravopodis D., Weinstein Y., and Ihle J.N. Erythropoietin induces activation of STAT5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16 (1996) 1622-1631
109. Ram P.A., Park S., Choi H.K., and Waxman D.J. Growth hormone activation of STAT1, STAT3, and STAT5 in rat liver. J. Biol. Chem. 271 (1996) 5929-5940
110. Ren R., Mayer B.J., Cichetti P., and Baltimore D. Identification of ten amino acid prolin-rich SH3 binding site. Science 259 (1993) 1157-1161
111. Ridderstrale M., and Tornqvist H. PI-3 kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 203 (1994) 306-310
112. Rozakis-Adcock M., and Kelly P.A. Mutational analysis of the ligand binding domain of the prolactin receptor. J. Biol. Chem. 266 (1991) 16472-16477
113. Rozakis-Adcock M., and Kelly P.A. Identification of ligand binding determinants of the prolactin receptor. J. Biol. Chem. 267 (1992) 7428-7433
114. Rui H., Djeu J.Y., Evans G.A., Kelly P.A., and Farrar W.L. Prolactin receptor triggering: evidence for rapid tyrosine kinase activation. J. Biol. Chem. 267 (1992) 24076-24081
115. Rui H., Kirken R.A., and Farrar W. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269 (1994) 5364-5368
116. Shirota M., Banville D., Ali S., Jolicoeur C., Boutin J.-M., Edery M., Djiane J., and Kelly P.A. Expression of two forms of prolactin receptor in rat ovary and liver. Mol. Endocrinol. 4 (1990) 1136-1142
117. Shuai K., Horvath C.M., Tsai Huang L.H., Qureshi S.A., Cowburn D., and Darnell Jr. J.E. Interferon activation of the transcription factor STAT91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76 (1994) 821-828
118. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., and Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of STATs 1, 3, and 5 by GH. Mol. Endocrinol. 10 (1996) 519-533
119. Somers W., Ultsch M., De Vos A.M., and Kossiakoff A.A. The X-ray structure of the growth hormone-prolactin receptor complex: receptor binding specificity developed through conformational variability. Nature 372 (1994) 478-481
120. Sotiropoulos A., Goujon L., Simonin G., Kelly P.A., Postel-Vinay M.C., and Finidori J. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132 (1993) 1863-1865
121. Sotiropoulos A., Perrot-Applanat M., Dinerstein H., Pallier A., Postel-Vinay M.C., Finidori J., and Kelly P.A. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 135 (1994) 1292-1298
122. Sotiropoulos A., Moutoussamy S., Binart N., Kelly P.A., and Finidori J. The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of STAT3. FEBS Lett. 369 (1995) 169-172
123. Sotiropoulos A., Moutoussamy S., Renaudie F., Clauss M., Kayser C., Gouilleux F., Kelly P.A., and Finidori J. Differential activation of STAT3 and STAT5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 10 (1996) 998-1009
124. Stahl N., and Yancopoulos G.D. The alphas, betas and kinases of cytokine receptor complexes. Cell 74 (1993) 587-590
125. Stahl N., Farruggella T.J., Boulton T.G., Zhong Z., Darnell Jr. J.E., and Yancopoulos G.D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267 (1995) 1349-1353
126. Sun X.J., Pons S., Asano T., Myers M.G., Glasheen E., and White M.F. The Fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271 (1996) 10583-10587
127. Taga T., and Kishimoto T. Cytokine receptors and signal transduction. FASEB J. 7 (1993) 3387-3396
128. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268 (1995) 251-255
129. Tourkine N., Schindler C., Larose M., and Houdebine L.M. Activation of Stat factors by prolactin, interferon-γ, growth hormones, and a tyrosine phosphatase inhibitor in rabbit primary mammary epithelial cells. J. Biol. Chem. 270 (1995) 20952-20961
130. VanderKuur J., Allevato G., Billestrup N., Norstedt G., and Carter-Su C. Growth hormone -promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270 (1995) 7587-7593
131. VanderKuur J.A., Wang X., Zhang L., Allevato G., Billestrup N., and Carter-Su C. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J. Biol. Chem. 270 (1995) 21738-21744
132. Wakao H., Gouilleux F., and Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13 (1994) 2182-2191
133. Wakao H., Harada N., Kitamura T., Mui A.L., and Miyajima A. Interleukin-2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J. 14 (1995) 2527-2535
134. Walter M.R., Windsor W.T., Nagabhusgan T.L., Lundell D.J., Lunn C.A., Zauodny P.J., and Narula S.K. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature 376 (1995) 230-235
135. Wang Y.D., Wong K., and Wood W.I. Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or JAK-STAT activation. J. Biol. Chem. 270 (1995) 7021-7024
136. Wang Y.D., and Wood W.I. Amino acids of the human growth hormone receptor that are required for proliferation and JAK-STAT signaling. Mol. Endocrinol. 9 (1995) 303-311
137. Wells J.A. Structural and functional basis for hormone binding and receptor oligomerization. Curr. Opin. Cell. Biol. 6 (1994) 163-173
138. Wells J.A. Binding in the growth hormone receptor complex. Proc. Natl. Acad. Sci. USA 93 (1996) 1-6
139. Wood T.J.J., Sliva D., Lobie P.E., Pircher T., Gouilleux F., Wakao H., Gustafsson J.A., Groner B., Norstedt G., and Haldosen L.A. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/STAT5. J. Biol. Chem. 270 (1995) 9448-9453